Share Name Share Symbol Market Type Share ISIN Share Description
Tyratech (DI) LSE:TYRU London Ordinary Share COM SHS USD0.001 (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 2.35p 2.20p 2.50p 2.35p 2.35p 2.35p 3,105 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Chemicals 4.6 -1.5 -0.7 - 3.48

Tyratech (DI) Share Discussion Threads

Showing 3576 to 3598 of 3600 messages
Chat Pages: 144  143  142  141  140  139  138  137  136  135  134  133  Older
DateSubjectAuthorDiscuss
27/6/2018
17:12
I've given up sometime ago. Better opps out there.
greedfear
13/6/2018
21:20
Merial Animal Health Co Ltd Corporate Information Address: No.818, Chuangxin No.2 Rd., High-te Nanchang, 330000 China Interesting - chinese - So probably a lot of push money behind the brand - Not sure where that leaves strapped for cash TYRU - Thoughts ?
pugugly
13/6/2018
21:05
Merial advertising heavily on UK TV. http://uk.frontline.com/frontline-plus-dogs
mudbath
06/6/2018
10:06
Looks like a big seller still around at 2.2 or 2.3 though the latter might be a buy.
pugugly
25/5/2018
20:32
If they need cash they could easily obtain cash through the issue of new shares at a much higher price than 3p - if you attempted to buy a reasonable sized stake(say a 5-10% stake) in the company at present, you would pay a great deal more than 3p on average a share I expect. Any potential buyer of such a stake would be given advance info, such as a supporting institution that would then hold them, selling new shares at a premium would enhance the current share price
clocktower
23/5/2018
07:33
The results are very encouraging. The impressive increase in turnover for the remaining products means they should continue to have low cash burn. Guardian is clearly being prepared for sale and will give them extra cash. With the expected further sales based cash from the Vamousse deal it appears to me that they won't need to have further fund raising. Maybe famous last words but to me the potential of the company is clear for all to see and it is clearly undervalued. GLA Nobby
nobbygnome
11/5/2018
09:42
Latest Interview https://www.youtube.com/watch?v=J2fysHOFRt4
ferris_bueller
09/5/2018
12:12
The Mite dust is being sold now, and as stated in the RNS they are on track to launch the PureScience Poultry mite product in France and Germany by the end of the year. "PureScience™ Poultry Mite unit sales up 250% on a moving annual total - Expanding into Europe Outsmart® sales to SmartPak showing sharp increase for early 2018"
clocktower
09/5/2018
12:04
S L A good point about the valuation. It is clearly ridiculous but I guess whilst there is any spectre of a further fundraising it won't reach a realistic valuation. However, I do see some upside from here!
nobbygnome
09/5/2018
11:49
I see this as a good long term play but all of their offerings take far too long to get to market for my liking. In early September 2017 Bruno stated the mite dust was ‘very close’ to being available, now it’s the end of this year, at the earliest. Now we’re told the U.S. market is worth $5m. Wow. Sales are up a whopping 250%. Sounds fine if you are unaware of where we’re coming from. It will be the end of 2019 before we see any meaningful contribution from Europe imo. Their other offerings might interest someone younger than myself, lol. On that basis I have drastically reduced my holding here but will let the remainder ride. GLA
michaelsadvfn
09/5/2018
11:06
An interesting RNS. The main content that was news to me was the field trials of the red mite dust (for Europe) showing 90% control for up to 4 months from one dose; and lab evidence of effectiveness for coccidiosis (plus the in vivo evidence of reduced lesions). I think the ruminants material is a recycling of the old Mondelez work. They could have rolled this up into the 2017 results that they promise this month. Presumably they've issued a separate RNS because they think the share price is undervalued. They are looking to bring in an industry investor and it would not look good if they bought back shares at 3p and sold them again at 2 to 2.5p. Finally, a thought experiment. Imagine a pharma company came to market saying it had promising lab results for a novel product whose efficacy and commercial viability had been established in other fields of use and which addresses an underserved $1bn market and it wanted funds to take the trials into the clinic. What would its market cap be on floating?
somerset lad
09/5/2018
09:53
There is clearly a large buyer as well as a seller but once the seller is out of the way, this could soon reach 3p imo. Many will be buying for long term growth, as the company have now proved themselves, having sold Vamousse and returned funds to investors, while retaining the cash they believe will see them through with rising sales. The sales increase could continue to out perform expectations even.
clocktower
09/5/2018
09:36
Nobby - Agreed - Looks as though the big seller still there in blocks of 200K but MM's widening the spread against potential buyers-
pugugly
09/5/2018
09:13
>> pug I agree that the only blot on the horizon is that they may need more money, although not in the short term. However, clearly turnover from the remaining products is going up so perhaps it won't need to happen. Not sure Bruno will tell me anything at the moment 🤔...... Nobby
nobbygnome
09/5/2018
08:59
I cannot see any worries about the cash burn following the sale of Vamousee in December. The important fact, is the increase in sales to over 250% in the Poultry Mite treatment. This is I forecast is going to be a huge market for the company, and a very profitable one imo. Far bigger than Vamousee - hence the sale, and at a great profit at that. DYOR
clocktower
09/5/2018
08:11
Nice one - but pity no information on cash burn - possibly a negative Someone will need to chase Bruno. Nobby ? One for you.
pugugly
09/5/2018
08:08
Moving to phase 2 should show the way to increasing momentum, so can't see a collapse in the share price in the short or medium term.
corrientes
09/5/2018
08:03
Very good statement of progress from the company, all looking positive for the future.
clocktower
04/5/2018
16:18
Decent buy here today and talking of STL, it seem like a little volume pick up today. Doubt if its the shark that mud is hoping to see though.
clocktower
01/5/2018
20:02
>> mud Only just seen your post from April 17th so thanks for the credit. Yes I called it exactly correctly. The management are a bunch of amateurs and you never know I might be helping them out soon now I am retired (very early)! Nobby
nobbygnome
01/5/2018
17:45
Seriously, my TYR(U) friends there has never been a better time to get invested in uranium. Perfect storm!
greedfear
17/4/2018
10:19
That's the one PUGUGLY. Although it is some nine years ago now,I remember vividly buying 1 million STL at one pence.Some critics say Stilo has not delivered quickly enough and fair enough the story has had many chapters.It all looks becalmed at the moment,just as the sea looked placid in Jaws,just before the shark struck ! I hope to be able detect its outline below the surface before it lunges at the target.
mudbath
17/4/2018
10:02
mudbath - you mean like this "mudbath - 28 Oct'09 - 09:42 - 143 of 155 Off topic Stilo @ 1.3 pence are a screaming buy and also a most interesting microcap story in the making." !!!!
pugugly
Chat Pages: 144  143  142  141  140  139  138  137  136  135  134  133  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20180719 19:35:56